The RNA-binding protein HuR contributes to neuroinflammation by promoting C-C chemokine receptor 6 (CCR6) expression on Th17 cells.

In both multiple sclerosis and experimental autoimmune encephalomyelitis (EAE), the C-C chemokine receptor 6 (CCR6) is critical for pathogenic T helper 17 (Th17) cell migration to the central nervous system (CNS). Whereas many cytokines and their receptors are potently regulated via post-transcriptional mechanisms in response to various stimuli, how CCR6 expression is post-transcriptionally regulated in Th17 cells is unknown. Here, using RNA-binding protein HuR conditional knock-out (KO) and wild-type (WT) mice, we present evidence that HuR post-transcriptionally regulates CCR6 expression by binding to and stabilizing Ccr6 mRNA and by promoting CCR6 translation. We also found that HuR down-regulates several microRNA expressions, which could target the 3\u27-UTR of Ccr6 mRNA for decay. Accordingly, knock-out of HuR reduced CCR6 expression on Th17 cells and impaired their migration to CNS compared with the response of WT Th17 cells and thereby ameliorated EAE. Together, these findings highlight how HuR contributes to Th17 cell-mediated autoimmune neuroinflammation and support the notion that targeting HuR might be a potential therapeutic intervention for managing autoimmune disorders of the CNS

Multi-Objective Gust Load Alleviation Control Designs for an Aeroelastic Wind Tunnel Demonstration Wing

This paper presents several control and gust disturbance estimation techniques applied to a mathematical model of a physical flexible wing wind tunnel model used in ongoing tests at the University of Washington Aeronautical Laboratory's Kirsten Wind Tunnel. Three methods of gust disturbance estimation are presented, followed by three control methods: LQG, Basic Multi-Objective (BMO), and a novel Multi-Objective Prediction Correction (MOPC) controller. The latter of which augments a multi-objective controller, and attempts to correct for errors in the disturbance estimate. A simplified linear simulation of the three controllers is performed and a simple MIMO stability and robustness assessment is performed. Then, the same controllers are simulated in a higher fidelity Simulink environment that captures sampling, saturation and noise effects. This preliminary analysis indicates that the BMO controller provides the best performance and largest stability margins

Multi-Objective Optimal Control of the 6-DoF Aeroservoelastic Common Research Model with Aspect Ratio 13.5 Wing

A new 6-DoF aeroservoelastic (ASE) Common Research Model (CRM) provided by The Boeing Company with aspect ratio 13.5 and 17 control surfaces per wing is utilized to demonstrate combined tracking and optimal multi-objective control. The multi-objective controller is derived on the closed loop tracking controller, and utilizes state and gust estimates provided by an extended state observer. Various methods of model reduction useful for control and estimation are presented. A computationally efficient MATLAB/Simulink simulation is presented which includes actuator dynamics, rate and deflection saturation limits, and gust disturbance inputs. The platform is used to demonstrate excellent 6-DoF tracking control performance coupled with the multi-objective controller, which is shown to effectively reduce structural mode movement, wing root bending moment, and drag. State and gust estimation is also shown to perform well, even when derived and/or implemented with significantly fewer states than the original full-sized model

Real-Time Adaptive Drag Minimization Wind Tunnel Investigation of a Flexible Wing with Variable Camber Continuous Trailing Edge Flap System

This paper reports the results of a recently completed real-time adaptive drag minimization wind tunnel investigation of a highly flexible wing wind tunnel model equipped with the Variable Camber Continuous Trailing Flap (VCCTEF) technology at the University of Washington Aeronautical Laboratory (UWAL). The wind tunnel investigation is funded by NASA SBIR Phase II contract with Scientific Systems Company, Inc. (SSCI) and University of Washington (UW) as a subcontractor. The wind tunnel model is a sub-scale Common Research Model (CRM) wing constructed of foam core and fiberglass skin and is aeroelastically scaled to achieve a wing tip deflection of 10% of the wing semi-span which represents a typical wing tip deflection for a modern transport such as Boeing 787. The jig-shape twist of the CRM wing is optimized using a CART3D aero-structural model to achieve the minimum induced drag for the design cruise lift coefficient of 0.5. The wing is equipped with two chord wise cambered segments for each of the six span wise flap sections for a total of 12 individual flap segments that comprise the VCCTEF system. Each of the 12 flap segments is actively controlled by an electric servo-actuator. The real-time adaptive drag optimization strategy includes an on-board aerodynamic model identification, a model excitation, and a real-time drag optimization. The on-board aerodynamic model is constructed parametrically as a function of the angle of attack and flap positions to model the lift and drag coefficients of the wing. The lift coefficient models include a linear model and a second-order model. The drag coefficient models include a quadratic model and a higher-order up to 6th-order model to accurately model the drag coefficient at high angles of attack. The onboard aerodynamic model identification includes a recursive least-squares (RLS) algorithm and a batch least-squares (BLS) algorithm designed to estimate the model parameters. The model excitation method is designed to sample the input set that comprises the angle of attack and the flap positions. Three model excitation methods are developed: random excitation method, sweep method, and iterative angle-of-attack seeking method. The real-time drag optimization includes a generic algorithm developed by SSCI and several optimization methods developed by NASA which include a second-order gradient Newton-Raphson optimization method, an iterative gradient optimization method, a pseudo-inverse optimization method, an analytical optimization method, and an iterative refinement optimization method. The first wind tunnel test entry took place in September 2017. This test revealed major hardware issues and required further redesign of the flap servo mechanisms. The second test entry took place in April 2018. However, the test was not successful due to the issues with the onboard aerodynamic model identification RLS algorithm which incorrectly identified model parameters. This test also provides an experimental comparison study between the VCCTEF and a variable camber discrete trailing edge flap (VCDTEF) without the elastomer transition mechanisms. The experimental result confirms the benefit of the VCCTEF which produces lower drag by 5% than the VCDTEF. The third and final test entry took place in June 2018 after the issues with the RLS algorithm have been identified and corrected. Additional improvements were implemented. These include the BLS algorithm, the iterative angle-of-attack seeking method, the iterative gradient optimization method, and the pseudo-inverse optimization method. The test objectives were successfully demonstrated as the real-time drag optimization identifies several optimal solutions at off-design lift coefficients. The iterative gradient optimization method is found to achieve up to 4.7% drag reduction for the off-design lift coefficient of 0.7. The pseudo-inverse optimization method which does not require the drag coefficient model is found to be quite effective in reducing drag. Up to 9.4% drag reduction for the off-design lift coefficient of 0.7 is achieved with the pseudo-inverse optimization method. The wind tunnel investigation demonstrates the potential of real-time drag optimization technology. Several new capabilities are developed that could enable future adaptive wing technologies for flexible wings equipped with drag control devices such as the VCCTEF

The Grizzly, February 18, 1983

Rally at Bomberger: Students Protest Criticism • Rushes, Administration Meet Before Pledging • Editorial: Staff Members Defend Grizzly • USGA Notes • Letters to the Editor: Letter to the Editor Receives Support; Constructive Criticism Appreciated; Student Interest Sparked; Irresponsible Groups Cause Anger • Is Reaganomics a Reality? • Admissions Standards at Ursinus • President\u27s Corner • Happy Birthday to U • Talent Show Tonight • Occupational Hazards • Fighting Ursini Head to MACs Optimistically • Inconsistency Still Haunting Women\u27s Basketball • Gymnastics Ranked 13th • Badminton Team Tops Rosemont and Moravian • Lady Swimmers Boast 9-1 Record • Werley\u27s Record Speaks for Itselfhttps://digitalcommons.ursinus.edu/grizzlynews/1094/thumbnail.jp

Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial

Background Negative symptoms of schizophrenia represent deficiencies in emotional responsiveness, motivation, socialisation, speech and movement. When persistent, they are held to account for much of the poor functional outcomes associated with schizophrenia. There are currently no approved pharmacological treatments. While the available evidence suggests that a combination of antipsychotic and antidepressant medication may be effective in treating negative symptoms, it is too limited to allow any firm conclusions. Objective To establish the clinical effectiveness and cost-effectiveness of augmentation of antipsychotic medication with the antidepressant citalopram for the management of negative symptoms in schizophrenia. Design A multicentre, double-blind, individually randomised, placebo-controlled trial with 12-month follow-up Setting Adult psychiatric services, treating people with schizophrenia. Participants Inpatients or outpatients with schizophrenia, on continuing, stable antipsychotic medication, with persistent negative symptoms at a criterion level of severity. Interventions Eligible participants were randomised 1 : 1 to treatment with either placebo (one capsule) or 20 mg of citalopram per day for 48 weeks, with the clinical option at 4 weeks to increase the daily dosage to 40 mg of citalopram or two placebo capsules for the remainder of the study. Main Outcome Measures The primary outcomes were quality of life measured at 12 and 48 weeks assessed using the Heinrich’s Quality of Life Scale, and negative symptoms at 12 weeks measured on the negative symptom subscale of the Positive and Negative Syndrome Scale. Results No therapeutic benefit in terms of improvement in quality of life or negative symptoms was detected for citalopram over 12 weeks or at 48 weeks, but secondary analysis suggested modest improvement in the negative symptom domain, avolition/amotivation, at 12 weeks (mean difference –1.3, 95% confidence interval–2.5 to–0.09). There were no statistically significant differences between the two treatment arms over 48-week follow-up in either the health economics outcomes or costs, and no differences in the frequency or severity of adverse effects, including corrected QT interval prolongation. Limitations The trial under-recruited, partly because cardiac safety concerns about citalopram were raised, with the 62 participants recruited falling well short of the target recruitment of 358. Although this was the largest sample randomised to citalopram in a randomised controlled trial of antidepressant augmentation for negative symptoms of schizophrenia and had the longest follow-up, the power of statistical analysis to detect significant differences between the active and placebo groups was limited. Conclusion Although adjunctive citalopram did not improve negative symptoms overall, there was evidence of some positive effect on avolition/amotivation, recognised as a critical barrier to psychosocial rehabilitation and achieving better social and community functional outcomes. Comprehensive assessment of side-effect burden did not identify any serious safety or tolerability issues. The addition of citalopram as a long-term prescribing strategy for the treatment of negative symptoms may merit further investigation in larger studies. Future Work Further studies of the viability of adjunctive antidepressant treatment for negative symptoms in schizophrenia should include appropriate safety monitoring and use rating scales that allow for evaluation of avolition/amotivation as a discrete negative symptom domain. Overcoming the barriers to recruiting an adequate sample size will remain a challenge.</p

Mathematical modelling of nonlinear thermal radiation effects on EMHD peristaltic pumping of viscoelastic dusty fluid through a porous medium duct

Biologically-inspired propulsion systems are currently receiving significant interest in the aerospace sector. Since many spacecraft propulsion systems operate at high temperatures, thermal radiation is important as a mode of heat transfer. Motivated by these developments, in the present article, the influence of nonlinear thermal radiation (via the Rosseland diffusion flux model) has been studied on the laminar, incompressible, dissipative EMHD (Electro-magneto-hydrodynamic) peristaltic propulsive flow of a non-Newtonian (Jefferys viscoelastic) dusty fluid containing solid particles through a porous planar channel. The fluid is electrically-conducting and a constant static magnetic field is applied transverse to the flow direction (channel walls). Slip effects are also included. Magnetic induction effects are neglected. The mathematical formulation is based on continuity, momentum and energy equations with appropriate boundary conditions, which are simplified by neglecting the inertial forces and taking the long wavelength and lubrication approximations. The boundary value problem is then rendered non-dimensional with appropriate variables and the resulting system of reduced ordinary differential equations is solved analytically. The impact of various emerging parameters dictating the non-Newtonian propulsive flow i.e. Prandtl number, radiation parameter, Hartmann number, permeability parameter, Eckert number, particle volume fraction, electric field and slip parameter are depicted graphically. Increasing particle volume fraction is observed to suppress temperature magnitudes. Furthermore the computations demonstrate that an increase in particle volume fraction reduces the pumping rate in retrograde pumping region whereas it causes the opposite effect in the co-pumping region. The trapping mechanism is also visualized with the aid of streamline contour plots. Increasing thermal radiation elevates temperatures. Increasing Hartmann (magnetic body force) number decreases the size of the trapping bolus whereas the quantity of the does not effected. Conversely increasing particle volume fraction reduces the magnitude of the trapping bolus whereas the number of trapped bolus remains constant

Patterns of Plant Biomass Partitioning Depend on Nitrogen Source

Nitrogen (N) availability is a strong determinant of plant biomass partitioning, but the role of different N sources in this process is unknown. Plants inhabiting low productivity ecosystems typically partition a large share of total biomass to belowground structures. In these systems, organic N may often dominate plant available N. With increasing productivity, plant biomass partitioning shifts to aboveground structures, along with a shift in available N to inorganic forms of N. We tested the hypothesis that the form of N taken up by plants is an important determinant of plant biomass partitioning by cultivating Arabidopsis thaliana on different N source mixtures. Plants grown on different N mixtures were similar in size, but those supplied with organic N displayed a significantly greater root fraction. 15N labelling suggested that, in this case, a larger share of absorbed organic N was retained in roots and split-root experiments suggested this may depend on a direct incorporation of absorbed amino acid N into roots. These results suggest the form of N acquired affects plant biomass partitioning and adds new information on the interaction between N and biomass partitioning in plants

Scientific Opinion on Exploring options for providing advice about possible human health risks based on the concept of Threshold of Toxicological Concern (TTC)

&lt;p&gt;Synthetic and naturally occurring substances present in food and feed, together with their possible breakdown or reaction products, represent a large number of substances, many of which require risk assessment. EFSA’s Scientific Committee was requested to evaluate the threshold of toxicological concern (TTC) approach as a tool for providing scientific advice about possible human health risks from low level exposures, its applicability to EFSA’s work, and to advise on any additional data that might be needed to strengthen the underlying basis of the TTC approach. The Scientific Committee examined the published literature on the TTC approach, undertook its own analyses and commissioned an &lt;em&gt;in silico &lt;/em&gt;investigation of the databases underpinning the TTC approach. The Scientific Committee concluded that the TTC approach can be recommended as a useful screening tool either for priority setting or for deciding whether exposure to a substance is so low that the probability of adverse health effects is low and that no further data are necessary. The following human exposure threshold values are sufficiently conservative to be used in EFSA’s work; 0.15 μg/person per day for substances with a structural alert for genotoxicity, 18 μg/person per day for organophosphate and carbamate substances with anti-cholinesterase activity, 90 μg/person per day for Cramer Class III and Cramer Class II substances, and 1800 μg/person per day for Cramer Class I substances, but for application to all groups in the population, these values should be expressed in terms of body weight, i.e. 0.0025, 0.3, 1.5 and 30 μg/kg body weight per day, respectively. Use of the TTC approach for infants under the age of 6 months, with immature metabolic and excretory systems, should be considered on a case-by-case basis. The Committee defined a number of exclusion categories of substances for which the TTC approach would not be used.&lt;/p&gt

Acute Muscular Sarcocystosis: An International Investigation Among Ill Travelers Returning From Tioman Island, Malaysia, 2011-2012

A large outbreak of acute muscular sarcocystosis (AMS) among international tourists who visited Tioman Island, Malaysia, is described. Clinicians evaluating travelers returning ill from Malaysia with myalgia, with or without fever, should consider AMS in their differential diagnosi